跳至主要内容
临床试验/NCT03593746
NCT03593746Unknown不适用

Effects of High Intensity Interval Training and Combined Training Associated With Photobiomodulation in Type 2 Diabetic (T2D) Patients: a Randomized Controlled Clinical Trial

University of Nove de Julho2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年8月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
2
主要终点
Glycemic control

研究概览

简要总结

Diabetes has become a widespread epidemic, primarily because of the increasing prevalence and incidence of type 2 diabetes (T2D). T2D is a significant cause of premature mortality and morbidity related to cardiovascular disease, blindness, kidney and nerve disease, and amputation.

Physical activity improves blood glucose control and can prevent or delay T2D, along with positively affecting lipids, blood pressure, cardiovascular events, mortality, and quality of life. At present, although physical activity is a key element in the prevention and management of T2D, the most effective exercise strategy (intensity, duration, and type of exercise) for improving glucose control and reducing cardiometabolic risk in type 2 diabetes has not been defined.

Studies with Light-Emitting Diode (LED) therapy have demonstrated its ability to promote pain relief, improve muscle and cardiopulmonary performance, minimize muscle fatigue, and stimulate wound healing. In relation to patients with T2D, who have prolonged conditions of hyperglycemia, studies to investigate the impact of photobiomodulation associated with physical training have not been found so far.

The objective of this study is to investigate the effects of different types of physical training associated with Light-Emitting Diode (LED) therapy on cardiometabolic status and quality of life in patients with T2D.

详细描述

Type 2 diabetes (T2D) is a significant health problem worldwide due to its high prevalence and mortality. It is chronic metabolic disorder characterized by hyperglycemia resulting from a relative deficiency in insulin through either reduced insulin secretion or reduced insulin action or both. The subsequent chronic hyperglycaemia causes glycation of tissues, which almost inevitably leads to acute disturbances in metabolism and long term end organ damage, especially the blood vessels, heart, and nerves, and severe health complications.

Individuals with T2D have reduced aerobic fitness characterized by lower peak pulmonary oxygen uptake. Many potential mechanisms could explain this impaired response, for example, reduced muscle blood flow and capillary density, defects in muscular oxygen diffusion, and lower mitochondrial oxygen utilization and function.

T2D is also associated with lower baroreflex sensitivity and abnormal chronotropic response, altering heart rate regulation. In addition, prolonged hyperglycemia in T2D causes a number of pathological changes in vascular endothelial cells, increasing the production of reactive oxygen species and inflammatory cytokines that cause mitochondrial dysfunction and oxidative damage.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years;
  • Confirmed diagnosis of type 2 diabetes;
  • Sedentary lifestyle in the last six months, according to the criteria established by the American Heart Association (AHA).

排除标准

  • Confirmed diagnosis of any (1) heart disease; (2) musculoskeletal disorder; (3) respiratory disease; (4) uncontrolled arterial hypertension; (5) peripheral neuropathy or (6) factors that limit the performance of any of the study evaluations and/or training.
  • During the study, individuals with a presence of less than 80% in the training sessions will be excluded.

结局指标

主要结局

Glycemic control

时间窗: Change from Baseline to 12 weeks

Evaluated by the percentage of glycated hemoglobin

Incremental shuttle walking test

时间窗: Change from Baseline to 12 weeks

Distance in meters

Functional exercise capacity

时间窗: Change from Baseline to 12 weeks

Oxygen consumption measurement during cardiopulmonary test

次要结局

  • Musculoskeletal Function(Change from Baseline to 12 weeks)
  • Other Biochemical Analyzes(Change from Baseline to 12 weeks)
  • Autonomic Nervous System(Change from Baseline to 12 weeks)
  • Body mass index (BMI)(Change from Baseline to 12 weeks)
  • Endothelial Function(Change from Baseline to 12 weeks)
  • Quality of Life Questionary(Change from Baseline to 12 weeks)
  • Physical Activity Questionnaire(Change from Baseline to 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

LUCIANA MARIA MALOSA SAMPAIO

Professor of the postgraduate program in Rehabilitation Sciences

University of Nove de Julho

研究点 (2)

Loading locations...

相似试验